FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Sonic Beam Therapy for Liver Gets Breakthrough

[ Price : $8.95]

FDA grants HistoSonics a breakthrough device designation for its novel sonic (acoustic energy) beam therapy histotripsy and its us...

Revance BLA Shot Down Over Inspection Findings

[ Price : $8.95]

FDA sends Revance Therapeutics a complete response letter on its BLA for daxibotulinumtoxinA for Injection, indicated for treating...

Complete Response on Stem Cell Transplant Therapy

[ Price : $8.95]

FDA issues Omeros a complete response letter on its BLA for narsoplimab as a treatment for hematopoietic stem cell transplant-asso...

IRB Review Needed for all IVD Studies: FDA

[ Price : $8.95]

FDA reminds in vitro diagnostic manufacturers that the agency requires an institutional review board review for all device clinica...

United Therapeutics Snubbed on Tyvaso DPI

[ Price : $8.95]

United Therapeutics receives an FDA complete response letter on its NDA for Tyvaso DPI (treprostinil) for treating pulmonary arter...

Latest Federal Register Notices

[ Price : $8.95]

FDA Review posts the Federal Register notices for the week ending 10/15/2021.

Lupin Pharma Recalls Irbesartan Over Impurity

[ Price : $8.95]

Lupin recalls all irbesartan and irbesartan/hydrochlorothiazide tablets after finding some active pharmaceutical ingredient batche...

Vaccine Panel Backs J&J Booster Vaccine

[ Price : $8.95]

An FDA advisory committee unanimously votes to recommend Johnson & Johnsons Covid-19 booster vaccine in all adults two months afte...

FDA Delays Moderna Adolescent Vaccine EUA: Reports

[ Price : $8.95]

FDA delays its decision on expanding a Moderna emergency use authorization for its Covid-19 vaccine in adolescents while it furthe...

FDA Needs Regulatory Competitiveness Official: ex-FDAer

[ Price : $8.95]

Former FDA associate commissioner Peter Pitts says FDA needs a deputy commissioner for regulatory competitiveness to aggressively ...